These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 197571
21. Arachidonic acid elicits endothelium-dependent release from the rabbit aorta of a constrictor prostanoid resembling prostaglandin endoperoxides. Pagano PJ, Lin L, Sessa WC, Nasjletti A. Circ Res; 1991 Aug; 69(2):396-405. PubMed ID: 1907227 [Abstract] [Full Text] [Related]
22. Prostaglandin endoperoxides IX. Characterization of rabbit aorta contracting substance (RCS) from guinea pig lung and human platelets. Svensson J, Hamberg M, Samuelsson B. Acta Physiol Scand; 1975 Jun; 94(2):222-8. PubMed ID: 1155178 [Abstract] [Full Text] [Related]
23. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma. Smith JB, Ingerman C, Silver MJ. J Clin Invest; 1976 Nov; 58(5):1119-22. PubMed ID: 993335 [Abstract] [Full Text] [Related]
24. Inhibition of PGE1-stimulated cAMP accumulation in human platelets by thromboxane a2. Miller OV, Johnson RA, Gorman RR. Prostaglandins; 1977 Apr; 13(4):599-609. PubMed ID: 193153 [Abstract] [Full Text] [Related]
32. Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence. Miller OV, Ayer DE, Gorman RR. Biochim Biophys Acta; 1982 Jun 11; 711(3):445-51. PubMed ID: 6285985 [Abstract] [Full Text] [Related]
33. Cerebral arterial smooth muscle contraction by thromboxane A2. Ellis EF, Nies AS, Oates JA. Stroke; 1977 Jun 11; 8(4):480-3. PubMed ID: 898244 [Abstract] [Full Text] [Related]
34. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. Gryglewski RJ, Bunting S, Moncada S, Flower RJ, Vane JR. Prostaglandins; 1976 Nov 11; 12(5):685-713. PubMed ID: 824685 [Abstract] [Full Text] [Related]
35. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets. Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP. Basic Clin Pharmacol Toxicol; 2005 Sep 11; 97(3):162-7. PubMed ID: 16128910 [Abstract] [Full Text] [Related]
36. Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazoles. Yoshimoto T, Yamamoto S, Hayaishi O. Prostaglandins; 1978 Oct 11; 16(4):529-40. PubMed ID: 725083 [Abstract] [Full Text] [Related]
37. Imidazole: a selective inhibitor of thromboxane synthetase. Moncada S, Bunting S, Mullane K, Thorogood P, Vane JR, Raz A, Needleman P. Prostaglandins; 1977 Apr 11; 13(4):611-8. PubMed ID: 558637 [Abstract] [Full Text] [Related]
38. A potent inhibitor of thromboxane A2 biosynthesis in aggregating human blood platelets. Gryglewski RJ, Zmuda A, Dembińska-Kieć A, Krecioch E. Pharmacol Res Commun; 1977 Feb 11; 9(2):109-16. PubMed ID: 866363 [No Abstract] [Full Text] [Related]